.png)
Tuberculosis Treatment Drugs Market by Product Type and Application - Global Industry Analysis & Forecast to 2027
Published On : September 2019 Pages : 146 Category: Pharma & Healthcare Report Code : HC095445
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Tuberculosis Treatment Drugs Market By Product Type (Active TB, and Latent TB) and Application (Hospital, Clinic and Durgstore) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Tuberculosis Treatment Drugs Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Top-down and bottom-up approaches are used to validate the global Tuberculosis Treatment Drugs Market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Drivers and Restraints
Low understanding adherence to prescription stays a worry hidden the event of MDR TB, with couple of powerful tranquilize choices in the market. This rush of antimicrobial medication opposition in Mycobacterium TB strains has provoked an overall activity through WHO-drove projects, for example, Directly Observed Therapy (DOT). Besides, coordinated efforts among universal associations, for example, Unitaid, WHO, UNICEF, and TB Alliance, concentrated on advancement of shorter treatment regimens to battle medicate opposition is tending to neglected medicinal needs, which is relied upon to drive advertise development.
Regional Insights
Asia Pacific ruled the market, this can be ascribed to high occurrence of the illness, expanding commonness of HIV-TB co-disease, rising populace mindfulness with respect to risks of drug consistence, and improving human services foundation.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Johnson & Johnson
- Lupin
- Novartis
- Macleods Pharmaceuticals
- Otsuka Pharmaceutical
- Pfizer
- Eli Lilly
- Labatec Pharma
- Mylan
- Sanofi
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Tuberculosis Treatment Drugs Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Active TB
o Latent TB
· Tuberculosis Treatment Drugs Market, By Applications, Estimates and Forecast, 2017-2027 ($Million)
o Hospital
o Clinic
o Durgstore
· Tuberculosis Treatment Drugs Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Johnson & Johnson
o Lupin
o Novartis
o Macleods Pharmaceuticals
o Otsuka Pharmaceutical
o Pfizer
o Eli Lilly
o Labatec Pharma
o Mylan
o Sanofi
· Tuberculosis Treatment Drugs Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Tuberculosis Treatment Drugs Market, By Country
o U.S. Tuberculosis Treatment Drugs Market
o Canada Tuberculosis Treatment Drugs Market
o Mexico Tuberculosis Treatment Drugs Market
o Europe
§ Europe Tuberculosis Treatment Drugs Market, By Country
o Germany Tuberculosis Treatment Drugs Market
o UK Tuberculosis Treatment Drugs Market
o France Tuberculosis Treatment Drugs Market
o Russia Tuberculosis Treatment Drugs Market
o Italy Tuberculosis Treatment Drugs Market
o Rest of Europe Tuberculosis Treatment Drugs Market
o Asia-Pacific
§ Asia-Pacific Tuberculosis Treatment Drugs Market, By Country
o China Tuberculosis Treatment Drugs Market
o Japan Tuberculosis Treatment Drugs Market
o South Korea Tuberculosis Treatment Drugs Market
o India Tuberculosis Treatment Drugs Market
o Southeast Asia Tuberculosis Treatment Drugs Market
o Rest of Asia-Pacific Tuberculosis Treatment Drugs Market
o South America
§ South America Tuberculosis Treatment Drugs Market
o Brazil Tuberculosis Treatment Drugs Market
o Argentina Tuberculosis Treatment Drugs Market
o Columbia Tuberculosis Treatment Drugs Market
o Rest of South America Tuberculosis Treatment Drugs Market
o Middle East and Africa
§ Middle East and Africa Tuberculosis Treatment Drugs Market
o Saudi Arabia Tuberculosis Treatment Drugs Market
o UAE Tuberculosis Treatment Drugs Market
o Egypt Tuberculosis Treatment Drugs Market
o Nigeria Tuberculosis Treatment Drugs Market
o South Africa Tuberculosis Treatment Drugs Market
o Rest of MEA Tuberculosis Treatment Drugs Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Tuberculosis Treatment Drugs Market, By Type
5.1. Introduction
5.2. Global Tuberculosis Treatment Drugs Revenue and Market Share by Type (2017-2027)
5.2.1. Global Tuberculosis Treatment Drugs Revenue and Revenue Share by Type (2017-2027)
5.3. Active TB
5.3.1. Global Active TB Revenue and Growth Rate (2017-2027)
5.4. Latent TB
5.4.1. Global Latent TB Revenue and Growth Rate (2017-2027)
6. Tuberculosis Treatment Drugs Market, By Application
6.1. Introduction
6.2. Global Tuberculosis Treatment Drugs Revenue and Market Share by Application (2017-2027)
6.2.1. Global Tuberculosis Treatment Drugs Revenue and Revenue Share by Application (2017-2027)
6.3. Hospital
6.3.1. Global Hospital Revenue and Growth Rate (2017-2027)
6.4. Clinic
6.4.1. Global Clinic Revenue and Growth Rate (2017-2027)
6.5. Durgstore
6.5.1. Global Durgstore Revenue and Growth Rate (2017-2027)
7. Tuberculosis Treatment Drugs Market, By Region
7.1. Introduction
7.2. Global Tuberculosis Treatment Drugs Revenue and Market Share by Regions
7.2.1. Global Tuberculosis Treatment Drugs Revenue by Regions (2017-2027)
7.3. North America Tuberculosis Treatment Drugs by Countries
7.3.1. North America Tuberculosis Treatment Drugs Revenue and Growth Rate (2017-2027)
7.3.2. North America Tuberculosis Treatment Drugs Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Tuberculosis Treatment Drugs by Countries
7.4.1. Europe Tuberculosis Treatment Drugs Revenue and Growth Rate (2017-2027)
7.4.2. Europe Tuberculosis Treatment Drugs Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Tuberculosis Treatment Drugs by Countries
7.5.1. Asia-Pacific Tuberculosis Treatment Drugs Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Tuberculosis Treatment Drugs Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Tuberculosis Treatment Drugs by Countries
7.6.1. South America Tuberculosis Treatment Drugs Revenue and Growth Rate (2017-2027)
7.6.2. South America Tuberculosis Treatment Drugs Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Tuberculosis Treatment Drugs by Countries
7.7.1. Middle East and Africa Tuberculosis Treatment Drugs Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Tuberculosis Treatment Drugs Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Johnson & Johnson
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Lupin
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Novartis
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Macleods Pharmaceuticals
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Otsuka Pharmaceutical
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Pfizer
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Eli Lilly
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Labatec Pharma
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Mylan
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Sanofi
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.1. Global Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Tuberculosis Treatment Drugs Market Forecast by Regions (2017-2027)
9.2.1. North America Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.1.1. United States Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.1.2. Canada Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.1.3. Mexico Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.2. Europe Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.2.1. Germany Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.2.2. France Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.2.3. UK Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.2.4. Russia Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.2.5. Italy Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.3. Asia-Pacific Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.3.1. China Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.3.2. Japan Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.3.3. Korea Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.3.4. India Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.4. South America Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.4.1. Brazil Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.4.2. Argentina Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.4.3. Columbia Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.4.4. Rest of South America Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.5. Middle East and Africa Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.5.3. Egypt Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.5.4. Nigeria Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.5.5. South Africa Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.5.6. Turkey Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Tuberculosis Treatment Drugs Market Forecast (2017-2027)
9.3. Tuberculosis Treatment Drugs Market Forecast by Type (2017-2027)
9.3.1. Tuberculosis Treatment Drugs Forecast by Type (2017-2027)
9.3.2. Tuberculosis Treatment Drugs Market Share Forecast by Type (2017-2027)
9.4. Tuberculosis Treatment Drugs Market Forecast by Application (2017-2027)
9.4.1. Tuberculosis Treatment Drugs Forecast by Application (2017-2027)
9.4.2. Tuberculosis Treatment Drugs Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Tuberculosis Treatment Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Tuberculosis Treatment Drugs Revenue and Revenue Share by Type (2017-2018)
Figure Global Active TB Revenue and Growth Rate (2017-2018)
Figure Global Latent TB Revenue and Growth Rate (2017-2018)
Table Global Tuberculosis Treatment Drugs Revenue and Revenue Share by Application (2017-2018)
Figure Global Hospital Revenue and Growth Rate (2017-2018)
Figure Global Clinic Revenue and Growth Rate (2017-2018)
Figure Global Durgstore Revenue and Growth Rate (2017-2018)
Table Global Tuberculosis Treatment Drugs Revenue by Regions (2017-2018)
Figure North America Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure North America Tuberculosis Treatment Drugs Revenue and Growth Rate (2017-2018)
Figure North America Tuberculosis Treatment Drugs by Countries (2017-2018)
Figure North America Tuberculosis Treatment Drugs Revenue (Million USD) by Countries (2017-2018)
Figure United States Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure United States Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Canada Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Mexico Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Europe Tuberculosis Treatment Drugs Revenue and Growth Rate (2017-2018)
Figure Europe Tuberculosis Treatment Drugs by Countries (2017-2018)
Figure Europe Tuberculosis Treatment Drugs Revenue (Million USD) by Countries (2017-2018)
Figure Germany Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Germany Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure France Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure UK Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Russia Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Italy Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Rest of Europe Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Asia-Pacific Tuberculosis Treatment Drugs Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Tuberculosis Treatment Drugs by Countries (2017-2018)
Figure Asia-Pacific Tuberculosis Treatment Drugs Revenue (Million USD) by Countries (2017-2018)
Figure China Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure China Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Japan Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Korea Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure India Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Southeast Asia Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure South America Tuberculosis Treatment Drugs Revenue and Growth Rate (2017-2018)
Figure South America Tuberculosis Treatment Drugs by Countries (2017-2018)
Figure South America Tuberculosis Treatment Drugs Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Brazil Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Argentina Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Columbia Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Rest of South America Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Middle East and Africa Tuberculosis Treatment Drugs Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Tuberculosis Treatment Drugs by Countries (2017-2018)
Figure Middle East and Africa Tuberculosis Treatment Drugs Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Saudi Arabia Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure United Arab Emirates Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Egypt Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Nigeria Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure South Africa Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Turkey Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Tuberculosis Treatment Drugs Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Table Johnson & Johnson Tuberculosis Treatment Drugs Financial Overview
Table Lupin Tuberculosis Treatment Drugs Financial Overview
Table Novartis Tuberculosis Treatment Drugs Financial Overview
Table Macleods Pharmaceuticals Tuberculosis Treatment Drugs Financial Overview
Table Otsuka Pharmaceutical Tuberculosis Treatment Drugs Financial Overview
Table Pfizer Tuberculosis Treatment Drugs Financial Overview
Table Eli Lilly Tuberculosis Treatment Drugs Financial Overview
Table Labatec Pharma Tuberculosis Treatment Drugs Financial Overview
Table Mylan Tuberculosis Treatment Drugs Financial Overview
Table Sanofi Tuberculosis Treatment Drugs Financial Overview
Figure Global Tuberculosis Treatment Drugs Revenue (Millions USD) and Growth Rate (2018-2025)
Table Tuberculosis Treatment Drugs Market Forecast by Regions (2018-2025)
Figure North America Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure United States Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Canada Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Mexico Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Europe Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Germany Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure France Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure UK Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Russia Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Italy Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Rest of Europe Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Asia-Pacific Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure China Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Japan Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Korea Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure India Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Southeast Asia Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure South America Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Brazil Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Argentina Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Columbia Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Rest of South America Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Middle East and Africa Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Saudi Arabia Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure United Arab Emirates Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Egypt Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Nigeria Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure South Africa Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Turkey Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Tuberculosis Treatment Drugs Market Forecast (2018-2025)
Figure Global Tuberculosis Treatment Drugs Forecast by Type (2018-2025)
Figure Global Tuberculosis Treatment Drugs Market Share Forecast by Type (2018-2025)
Figure Global Tuberculosis Treatment Drugs Forecast by Type (2018-2025)
Figure Global Tuberculosis Treatment Drugs Forecast by Application (2018-2025)
Figure Global Tuberculosis Treatment Drugs Market Share Forecast by Application (2018-2025)
Figure Global Tuberculosis Treatment Drugs Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|